Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review
Open Access
- 6 March 2015
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 95 (3) , 190-198
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired disorder of the hematopoietic stem cell that makes blood cells more sensitive to the action of complement. Patients experience intravascular hemolysis, smooth muscle dystonia, renal failure, arterial and pulmonary hypertension, recurrent infectious diseases and an increased risk of notably dreadful thrombotic complications. The diagnosis is made by flow cytometry. Efforts have been recently performed to improve the sensitivity and the standardization of this technique. PNH is frequently associated with aplastic anemia or low‐risk myelodysplasia and may be asymptomatic. Management of the classical form of PNH has been dramatically revolutionized by the development of eculizumab, which brings benefits in terms of hemolysis, quality of life, renal function, thrombotic risk, and life expectancy. Prophylaxis and treatment of arterial and venous thrombosis currently remain a challenge in PNH.Keywords
Funding Information
- Alexion Pharmaceuticals
- Fonds De La Recherche Scientifique - FNRS
- Fondation Mont-Godinne
This publication has 40 references indexed in Scilit:
- Use of CD157 in FLAER-based assays for high-sensitivity PNH granulocyte and PNH monocyte detectionCytometry Part B: Clinical Cytometry, 2013
- Management of Paroxysmal Nocturnal Hemoglobinuria in the Era of Complement Inhibitory TherapyHematology-American Society Hematology Education Program, 2011
- Thrombosis in Patients with Paroxysmal Nocturnal HemoglobinuriaSeminars in Thrombosis and Hemostasis, 2011
- Thrombosis in Paroxysmal Nocturnal Hemoglobinuria – insights into the role of complement in thrombosisThrombosis Research, 2010
- L’hémoglobinurie paroxystique nocturneLa Revue de Médecine Interne, 2010
- How I treat paroxysmal nocturnal hemoglobinuriaBlood, 2009
- Immune Pathogenesis of Paroxysmal Nocturnal HemoglobinuriaInternational Journal of Hematology, 2006
- Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assaysBritish Journal of Haematology, 2004
- The PNH phenotype cells that emerge in most patients after CAMPATH‐1H therapy are present prior to treatmentBritish Journal of Haematology, 1999
- Paroxysmal Nocturnal HemoglobinuriaA.M.A. Archives of Internal Medicine, 1957